Literature DB >> 27279357

Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).

Elizabeth S Gromisch1,2, Vance Zemon3, Roee Holtzer3,4, Nancy D Chiaravalloti5,6, John DeLuca5,6,7, Meghan Beier7, Eileen Farrell8, Stacey Snyder9, Laura C Schairer10, Lisa Glukhovsky3, Jason Botvinick3, Jessica Sloan3, Mary Ann Picone11, Sonya Kim12,13, Frederick W Foley3,11.   

Abstract

OBJECTIVE: Cognitive dysfunction is prevalent in multiple sclerosis. As self-reported cognitive functioning is unreliable, brief objective screening measures are needed. Utilizing widely used full-length neuropsychological tests, this study aimed to establish the criterion validity of highly abbreviated versions of the Brief Visuospatial Memory Test - Revised (BVMT-R), Symbol Digit Modalities Test (SDMT), Delis-Kaplan Executive Function System (D-KEFS) Sorting Test, and Controlled Oral Word Association Test (COWAT) in order to begin developing an MS-specific screening battery.
METHOD: Participants from Holy Name Medical Center and the Kessler Foundation were administered one or more of these four measures. Using test-specific criterion to identify impairment at both -1.5 and -2.0 SD, receiver-operating-characteristic (ROC) analyses of BVMT-R Trial 1, Trial 2, and Trial 1 + 2 raw data (N = 286) were run to calculate the classification accuracy of the abbreviated version, as well as the sensitivity and specificity. The same methods were used for SDMT 30-s and 60-s (N = 321), D-KEFS Sorting Free Card Sort 1 (N = 120), and COWAT letters F and A (N = 298).
RESULTS: Using these definitions of impairment, each analysis yielded high classification accuracy (89.3 to 94.3%).
CONCLUSIONS: BVMT-R Trial 1, SDMT 30-s, D-KEFS Free Card Sort 1, and COWAT F possess good criterion validity in detecting impairment on their respective overall measure, capturing much of the same information as the full version. Along with the first two trials of the California Verbal Learning Test - Second Edition (CVLT-II), these five highly abbreviated measures may be used to develop a brief screening battery.

Entities:  

Keywords:  MS; cognition; executive function; memory; neuropsychology

Mesh:

Year:  2016        PMID: 27279357     DOI: 10.1080/13854046.2016.1189597

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  5 in total

1.  Managing Cognitive Dysfunction in Multiple Sclerosis: A Snapshot of Changes in Screening, Assessment, and Treatment Practices.

Authors:  Elizabeth S Gromisch; John DeLuca; Ralph H B Benedict; Frederick W Foley
Journal:  Int J MS Care       Date:  2021-09-13

2.  D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability.

Authors:  Alice Riccardi; Marco Puthenparampil; Francesca Rinaldi; Mario Ermani; Paola Perini; Paolo Gallo
Journal:  Front Psychol       Date:  2019-01-24

3.  Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.

Authors:  Daniel Golan; Smadar Sagiv; Lea Glass-Marmor; Ariel Miller
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

Review 4.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

Review 5.  Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis.

Authors:  Jian Zhang; Rosa Cortese; Nicola De Stefano; Antonio Giorgio
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.